Britain’s medicine regulator says identified possible side effect of Oxford/AstraZeneca vaccine By Reuters

LONDON (Reuters) – Britain’s medicine regulator has identified a possible side-effect from COVID-19 vaccine developed by Oxford University and AstraZeneca (NASDAQ:AZN) involving rare brain blood clotting, chief executive June Raine said on Wednesday.

She added that its benefits outweighed the risks for the vast majority.